DNA Sequencing Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

 
Customer Support
+44 (0)1487 843 722

If you have any questions regarding this
report, please call us on the number above.

Chat with the Author
Call +44 (0)7870 204 848
 
Untitled Document

For further details on this market study,
please see the Report Description

Index

1. Introduction (p.14)

1.1 Introduction
1.2 Background
1.3 Market Questions

2. Participants (p.28)

2.1 Participants
2.2 Global Regions
2.3 Countries
2.4 Job Titles
2.5 Experience
2.6 Organisation Types
2.7 Roles
2.8 Main Purpose
2.9 Discussion

3. Fields (p.51)

3.1 Fields
3.2 2016 Study
3.3 2013 Study
3.4 Discussion

4. Sequencing Laboratory Location (p.57)

4.1 Location
4.2 Laboratory Location
4.3 Preferred external Laboratories
4.4 Discussion

5. Diseases (p.64)

5.1 Diseases
5.2 2016 Study
5.3 2015 Study
5.4 Discussion

6. Sequencing Methods (p.74)

6.1 Methods
6.2 2016 Study
6.3 2015 Study
6.4. Discussion

7. Sequencing Instruments (p.82)

7.1 Instruments
7.2 Findings
7.3 Discussion

8. Advantages and Disadvantages (p.87)

8.1 Advantages and Disadvantages
8.2 2016 Study
8.3 2015 Study
8.4 Discussion

9. Sequencing Applications (p.93)

9.1. Sequencing Applications
9.2 2016 Study
9.3 2015 Study
9.4. Discussion

10. Clonal Amplification (p.104)

10.1 Clonal Amplification
10.2 Current Amplification
10.3 Future Amplification

11. Sequencing Software (p.107)

11.1 Sequencing Software
11.2 2016 Study
11.3 2015 Study
11.4. Discussion

12. Sequencing Performance (p.124)

12.1 Sequencing Performance
12.2 Read Lengths
12.3 Sequencing Accuracy
12.4 Reads Per Run
12.5 Sequencing Costs
12.6 Discussion

13. Nucleic Acid Types (p.127)

13.1 Nucleotide Types
13.2 2016 Study
13.3 2015 Study
13.4 Biomarkers Types
13.5 Preferred Kit Suppliers
13.6 Discussion

14. Trends and Growth (p.135)

14.1 Sequencing Growth Trends
14.2 2016 Study
14.3 2015 Study
14.4 Discussion

15. Suppliers (p.142)

15.1 Suppliers
15.2 2016 Study
15.3 2015 Study
15.4 Discussion

16. Study Samples (p.156)

16.1 Study Samples
16.2 2016 Study
16.3 2015 Study
16.4 Discussion

17. Sample Preparation (p.161)

17.0 Sample Preparation
17.1 This Chapter
17.2 2016 Study
17.3 2015 Study

18. Sample Preparation Kits (p.164)

18.1 Sample Preparation Kits
18.2 Kits

19. Disease Biomarkers (p.169)

19.1 Biomarkers
19.2 2016 Study
19.3 2015 Study
19.4. Discussion

20. Costs and Throughput (p.175)

20.1 Sample Throughput and Costs
20.2 Sample Throughput
20.3 Sequencing Costs
20.4 Discussion

21. Discussion (p.180)

21.1 Discussion

Figures

Figure 2.1. Global regions of participants in SEQ 2016
Figure 2.2. Global regions of participants in SEQ 2015
Figure 2.3. Top ten countries of participants in SEQ 2016
Figure 2.4. Top ten countries of participants in SEQ 2015
Figure 2.5. Top ten job titles of participants in SEQ 2016
Figure 2.6. Top ten job titles of participants in SEQ 2015
Figure 2.7. Top ten experience levels in DNA and RNA sequencing, of SEQ 2016 participants
Figure 2.8. Top ten experience levels of participants in SEQ2015
Figure 2.9. Top ten organisation types of participants in SEQ 2016
Figure 2.10. Organisations types of participants in SEQ 2015
Figure 2.11. Roles of participants in SEQ 2016
Figure 2.12. Roles of participants in SEQ2015
Figure 2.13. Top ten main purposes of sequencing activities of participants in SEQ2015
Figure 3.1. Top ten fields of work relating to
Figure 3.2. Top ten fields of participants in SEQ2015
Figure 4.1. Laboratory locations of DNA/RNA sequencing of SEQ 2016 participants
Figure 4.2. Laboratory locations of DNA/RNA sequencing of SEQ 2016 participants
Figure 5.1. Top ten current disease areas relating to DNA/RNA sequencing of SEQ 2016 participants
Figure 5.2. Top ten future anticipated disease areas relating to DNA/RNA sequencing of SEQ 2016 participants
Figure 5.3. Top ten current disease areas relating to sequencing, of participants in SEQ2015
Figure 5.4. Top ten future disease areas relating to sequencing, of participants in SEQ2015
Figure 6.1. Top ten current sequencing methods of SEQ 2016 participants
Figure 6.2. Top ten future anticipated sequencing methods of SEQ 2016 participants
Figure 6.3. Top ten current sequencing techniques, of participants in SEQ2015
Figure 6.4. Top ten future sequencing techniques, of participants in SEQ2015
Figure 7.1. Top ten current sequencing instruments used by SEQ 2016 participants
Figure 7.2. Top ten future anticipated sequencing instruments of SEQ 2016 participants
Figure 8.1. Top ten advantages of the DNA sequencing techniques, of participants in SEQ2015
Figure 8.2. Top ten disadvantages of the DNA sequencing techniques, of participants in SEQ2015
Figure 9.1. Top ten current sequencing applications of SEQ 2016 participants
Figure 9.2. Top ten future sequencing applications of SEQ 2016 participants
Figure 9.3. Top ten current applications of sequencing activities, of participants in SEQ2015
Figure 9.4. Top ten future applications of sequencing activities, of participants in SEQ 2015
Figure 10.1. Current clonal amplification methods of SEQ 2016 participants
Figure 10.2. Future clonal amplification methods of SEQ 2016 participants
Figure 11.1. Top sequencing software (A – M) used by SEQ 2016 participants
Figure 11.2. Top sequencing software (A – M) used by SEQ 2016 participants
Figure 11.3. Software used in DNA sequencing, of participants in SEQ2015
Figure 13.1. Top ten current nucleotide types sequenced by SEQ 2016 participants
Figure 13.2. Top ten future anticipated nucleotide types to be sequenced by SEQ 2016 participants
Figure 13.3. Top ten current nucleic acids types in their sequencing activities, of participants in SEQ2015
Figure 13.4. Top ten future nucleic acids types in their sequencing activities, of participants in SEQ2015
Figure 14.1. Top ten recent sequencing growth trends of SEQ 2016 participants
Figure 14.2. Top ten future anticipated sequencing growth trends of SEQ 2016 participants
Figure 14.3. Top ten recent trend levels in their sequencing activities, of participants in SEQ2015
Figure 14.4. Top ten future anticipated trend levels in their sequencing activities, of participants in SEQ2015
Figure 15.1. Top ten current sequencing suppliers of SEQ 2016 participants
Figure 15.2. Top ten future sequencing suppliers of SEQ 2016 participants
Figure 15.3. Top ten current suppliers in their sequencing activities, of participants in SEQ2015
Figure 15.4. Top ten future anticipated suppliers in their sequencing activities, of participants in SEQ 2015
Figure 16.1. Top ten samples sequenced by SEQ 2016 participants
Figure 16.2. Top ten study samples in their sequencing activities, of participants in SEQ2015
Figure 17.1. Top ten sequencing sample preparation methods used by SEQ 2016 participants
Figure 17.2. Main sample preparation methods used in their sequencing activities, of participants in SEQ2015
Figure 18.1. The use of sample preparation kits in their sequencing activities, of participants in SEQ 2016
Figure 18.2. The use of sample preparation kits in their sequencing activities, of participants in SEQ 2015
Figure 18.2. The use of sample preparation kits in their sequencing activities, of participants in SEQ 2015
Figure 18.3. Preferred suppliers of sample preparation kits in their sequencing activities, of participants in SEQ 2016
Figure 18.4. Preferred suppliers of sample preparation kits in their sequencing activities, of participants in SEQ 2015
Figure 19.1. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2016
Figure 19.2. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2015
Figure 19.3. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2016
Figure 19.4. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2015
Figure 20.1. Top ten per-sample sequencing cost levels in their sequencing activities, of participants in SEQ2015

Figures

Table 2.1. Global regions of participants in SEQ 2016
Table 2.2. Global regions of participants in SEQ2015
Table 2.3. Countries of participants in SEQ 2016
Table 2.4. Countries of participants in SEQ2015
Table 2.5. Job titles of participants in SEQ 2016
Table 2.6. Job titles of participants in SEQ2015
Table 2.7. Experience levels in DNA and RNA sequencing, of SEQ 2016 participants
Table 2.8. Experience levels of participants in SEQ2015
Table 2.9. Organisation types of participants in SEQ 2016
Table 2.10. Organisations types of participants in SEQ2015
Table 2.11. Roles of participants in SEQ 2016
Table 2.12. Roles of participants in SEQ 2015
Table 2.13. Main purposes of sequencing activities of participants in SEQ2015

Table 3.1. Fields of work relating to DNA and RNA sequencing of SEQ 2016 participants
Table 3.2. Fields of participants in SEQ 2015
Table 4.1. Laboratory locations of DNA/RNA sequencing of SEQ 2016 participants
Table 5.1. Current disease areas relating to DNA/RNA sequencing of SEQ 2016 participants
Table 5.2. Anticipated future disease areas relating to DNA/RNA sequencing of SEQ 2016 participants
Table 5.3. Current disease areas relating to sequencing, of participants in SEQ2015
Table 5.4. Future disease areas relating to sequencing, of participants in SEQ2015
Table 6.1. Current sequencing methods of SEQ 2016 participants
Table 6.2. Future anticipated sequencing methods of SEQ 2016 participants
Table 6.3. Current sequencing techniques, of participants in SEQ2015
Table 6.4. Future sequencing techniques, of participants in SEQ2015
Table 7.1. Current sequencing instruments used by SEQ 2016 participants
Table 7.2. Future anticipated sequencing instruments of SEQ 2016 participants
Table 8.1. Advantages cited by 2016 end-users of the sequencing techniques they use
Table 8.2. Disadvantages cited by 2016 end-users of the sequencing techniques they use
Table 8.3. Top ten advantages of the DNA sequencing techniques, of participants in SEQ 2015
Table 8.4. Top ten disadvantages of the DNA sequencing techniques, of participants in SEQ2015
Table 9.1. Current sequencing applications of SEQ 2016 participants
Table 9.2. Future anticipated sequencing applications of SEQ 2016 participants
Table 9.3. Current applications of sequencing activities, of participants in SEQ2015
Table 9.4. Future applications of sequencing activities, of participants in SEQ 2015
Table 10.1. Current clonal amplification methods of SEQ 2016 participants
Table 10.2. Future clonal amplification methods of SEQ 2016 participants
Table 11.1. Top sequencing software (A – M) used by SEQ 2016 participants
Table 11.2. Top sequencing software (M – Z) used by SEQ 2016 participants
Table 11.3. Software used in DNA sequencing, of participants in SEQ2015
Table 13.1. Current nucleotide types sequenced by SEQ 2016 participants
Table 13.2. Top ten future anticipated nucleotide types to be sequenced by SEQ 2016 participants
Table 13.3. Current nucleic acids types in their sequencing activities, of participants in SEQ2015
Table 13.4. Future nucleic acids types in their sequencing activities, of participants in SEQ2015
Table 14.1. Recent sequencing growth trends of suppliers of SEQ 2016 participants
Table 14.2. Future anticipated sequencing growth trends of SEQ 2016 participants
Table 14.3. Recent trend levels in their sequencing activities, of participants in SEQ2015
Table 14.4. Future anticipated trend levels in their sequencing activities, of participants in SEQ2015
Table 15.1. Current sequencing suppliers of SEQ 2016 participants
Table 15.2. Future sequencing suppliers of SEQ 2016 participants
Table 15.3. Current suppliers in their sequencing activities, of participants in SEQ2015
Table 15.4 Future anticipated suppliers in their sequencing activities, of participants in SEQ 2015
Table 16.1. Samples sequenced sequenced by SEQ 2016 participants
Table 16.2. Study samples in their sequencing activities, of participants in SEQ2015
Table 17.1. Sequencing sample preparation methods used by SEQ 2016 participants
Table 17.2. Main sample preparation methods used in their sequencing activities, of participants in SEQ2015
Table 18.1. The use of sample preparation kits in their sequencing activities, of participants in SEQ 2016
Table 18.3. Preferred suppliers of sample preparation kits in their sequencing activities, of participants in SEQ 2016
Table 19.1. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2016
Table 19.2. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2015
Table 19.3. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2016
Table 19.4. The study of disease biomarkers using DNA or RNA sequencing, by participants in SEQ 2015

Table 20.1. Sample throughput levels in DNA and RNA sequencing, indicated by end-users in SEQ 2016
Table 20.2. Sample throughput levels in DNA and RNA sequencing, indicated by end-users in SEQ 2015
Table 20.3. Per-sample sequencing cost levels in their DNA sequencing activities, of participants in SEQ2015